Team Roar-The Scarlett Fund


Thank You

Since 2014, Team Roar’s dedicated participants and generous donors have raised over $4 million for pediatric cancer research through the Scarlett Fund at MSK Kids, MSK’s pediatric program. This support makes progress possible, and we’re so grateful for all this community is doing.

Watch this video to hear a special thank you from Dr. Andrew Kung, Chair of the Department of Pediatrics at MSK Kids and Lila Acheson Wallace Chair for Pediatric Research.


Join Team Roar-The Scarlett Fund

Join Team Roar through the MSK fundraising programs Cycle for Survival and Fred’s Team. If you are not participating, please consider donating — 100% of every dollar goes directly to cancer research at MSK.


Cycle for Survival

Cycle for Survival accelerates progress in rare cancer research, bringing new and better treatment options to people around the world.

Join us in 2025! Fill out our interest form to be the first to know when registration opens.

Fred's Team

Fred's Team

Fred’s Team runners add more meaning to their miles by raising money for lifesaving cancer research at MSK. Visit Team Roar's TCS New York City Marathon team page to donate.


About Team Roar-The Scarlett Fund

When Scarlett James was 6 years old, she was diagnosed with T cell lymphoma, a rare pediatric cancer. Her parents brought her to MSK Kids, where she was cared for by a world-class team of pediatric oncologists, nurses, and child life specialists, and she received the most advanced treatments available. Today, Scarlett is thriving — she is now in eighth grade and enjoys horseback riding, art, and history. Scarlett’s experience inspired the James family to raise money for critical research through the Scarlett Fund at MSK Kids so that children with cancer can have access to more effective treatments.

Despite significant progress in combating childhood cancers, the primary treatment is still chemotherapy, which is harmful to not just cancer cells but healthy cells as well. This can lead to long-term side effects — an especially big problem for children, who are still growing. Precision medicine is a promising advance that can target and treat the specific genetic mutation that causes a person’s cancer, reducing the potential for long-term damage. The Scarlett Fund provides key support for the Pediatric Translational Medicine Program at MSK Kids. When researchers have the tools to help them identify the genes causing each child’s cancer, they have a better chance of developing targeted therapies that can improve outcomes and have fewer side effects.